Anderson RM, Hadjichrysanthou C, Evans S, Wong MM. Why do so many clinical trials of therapies for Alzheimer’s disease fail? Lancet. 2017;390(10110):2327–9. https://doi.org/10.1016/S0140-6736(17)32399-1.
Article
Google Scholar
Arvanitakis Z, Leurgans SE, Fleischman DA, Schneider JA, Rajan KB, Pruzin JJ, Shah RC, Evans DA, Barnes LL, Bennett DA. Memory complaints, dementia, and neuropathology in older blacks and whites. Ann Neurol. 2018;83(4):718–29. https://doi.org/10.1002/ana.25189.
Article
Google Scholar
Ávila-Villanueva M, Fernández-Blázquez MA. Subjective cognitive decline as a preclinical marker for Alzheimer’s disease: the challenge of stability over time. Frontiers in aging neuroscience. 2017;9:377. https://doi.org/10.3389/fnagi.2017.00377.
Article
Google Scholar
Barnes LL, Shah RC, Aggarwal NT, Bennett DA, Schneider JA. The Minority Aging Research Study: ongoing efforts to obtain brain donation in African Americans without dementia. Curr Alzheimer Res. 2012;9(6):734–45. https://doi.org/10.2174/156720512801322627.
Article
CAS
Google Scholar
Barnes LL, Schneider JA, Boyle PA, Bienias JL, Bennett DA. Memory complaints are related to Alzheimer disease pathology in older persons. Neurology. 2006;67:1581–5. https://doi.org/10.1212/01.wnl.0000242734.16663.09.
Article
CAS
Google Scholar
Barnes LL, Yumoto F, Capuano A, Wilson RS, Bennett DA, Tractenberg RE. Examination of the factor structure of a global cognitive function battery across race and time. J Int Neuropsychol Soc. 2016;22(1):66–75. https://doi.org/10.1017/S1355617715001113.
Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48. https://doi.org/10.18637/jss.v067.i01.
Article
Google Scholar
Beam CR, Kaneshiro C, Jang JY, Reynolds CA, Pedersen NL, Gatz M. Differences between women and men in incidence rates of dementia and Alzheimer’s disease. Journal of Alzheimer’s Disease. 2018;64(4):1077–83. https://doi.org/10.3233/JAD-180141.
Article
Google Scholar
Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol). 1995;57(1):289–300. https://doi.org/10.1111/j.2517-6161.1995.tb02031.x.
Article
Google Scholar
Bennett DA, Buchman AS, Boyle PA, Barnes LL, Wilson RS, Schneider JA. Religious orders study and rush memory and aging project. Journal of Alzheimer’s disease. 2018;64(s1):S161–89. https://doi.org/10.3233/JAD-179939.
Article
Google Scholar
Blanken AE, Nation DA. Does gender influence the relationship between high blood pressure and dementia? Highlighting areas for further investigation. Journal of Alzheimer’s Disease. 2020;78(1):23–48. https://doi.org/10.3233/JAD-200245.
Article
Google Scholar
Cummings JL, Cole G. Alzheimer disease. Jama. 2002;287(18):2335–8. https://doi.org/10.1001/jama.287.18.2335.
Article
CAS
Google Scholar
Dadar M, Maranzano J, Ducharme S, Collins DL, Alzheimer’s Disease Neuroimaging Initiative. White matter in different regions evolves differently during progression to dementia. Neurobiol Aging. 2019;76:71–9. https://doi.org/10.1016/j.neurobiolaging.2018.12.004.
Article
Google Scholar
Fisher DW, Bennett DA, Dong H. Sexual dimorphism in predisposition to Alzheimer’s disease. Neurobiol Aging. 2018;70:308–24. https://doi.org/10.1016/j.neurobiolaging.2018.04.004.
Article
CAS
Google Scholar
Filon JR, Intorcia AJ, Sue LI, Vazquez Arreola E, Wilson J, Davis KJ, Serrano GE. Gender differences in Alzheimer disease: brain atrophy, histopathology burden, and cognition. J Neuropathol Exp Neurol. 2016;75(8):748–54. https://doi.org/10.1093/jnen/nlw047.
Article
Google Scholar
Gannon OJ, Robison LS, Custozzo AJ, Zuloaga KL. Sex differences in risk factors for vascular contributions to cognitive impairment & dementia. Neurochem Int. 2019;127:38–55. https://doi.org/10.1016/j.neuint.2018.11.014.
Article
CAS
Google Scholar
Gauthier S, Albert M, Fox N, Goedert M, Kivipelto M, Mestre-Ferrandiz J, Middleton LT. Why has therapy development for dementia failed in the last two decades? Alzheimer’s & Dementia. 2016;12(1):60–4. https://doi.org/10.1016/j.jalz.2015.12.003.
Article
Google Scholar
Hebert LE, Scherr PA, McCann JJ, Beckett LA, Evans DA. Is the risk of developing Alzheimer’s disease greater for women than for men? Am J Epidemiol. 2001;153(2):132–6. https://doi.org/10.1093/aje/153.2.132.
Article
CAS
Google Scholar
Heser K, Kleineidam L, Wiese B, Oey A, Roehr S, Pabst A, Wagner M. Subjective cognitive decline may be a stronger predictor of incident dementia in women than in men. Journal of Alzheimer’s Disease. 2019;68(4):1469–78. https://doi.org/10.3233/JAD-180981.
Article
Google Scholar
Hill NL, Mogle J, Bhargava S, Whitaker E, Bhang I, Capuano AW, Barnes LL. Differences in the associations between memory complaints and depressive symptoms among Black and White older adults. J Gerontol Series B. 2020;75(4):783–91. https://doi.org/10.1093/geronb/gby091.
Article
Google Scholar
Holland D, Desikan RS, Dale AM, McEvoy LK. Higher rates of decline for women and apolipoprotein E ε4 carriers. Am J Neuroradiol. 2013;34(12):2287–93. https://doi.org/10.3174/ajnr.A3601.
Article
CAS
Google Scholar
Huebschmann AG, Huxley RR, Kohrt WM, Zeitler P, Regensteiner JG, Reusch JE. Sex differences in the burden of type 2 diabetes and cardiovascular risk across the life course. Diabetologia. 2019;62(10):1761–72. https://doi.org/10.1007/s00125-019-4939-5.
Article
Google Scholar
Irvine K, Laws KR, Gale TM, Kondel TK. Greater cognitive deterioration in women than men with Alzheimer’s disease: a meta analysis. J Clin Exp Neuropsychol. 2012;34(9):989–98. https://doi.org/10.1080/13803395.2012.712676.
Article
Google Scholar
Jessen F, Amariglio RE, Buckley RF, van der Flier WM, Han Y, Molinuevo JL, Wagner M. The characterisation of subjective cognitive decline. The Lancet Neurology. 2020;19(3):271–8. https://doi.org/10.1016/S1474-4422(19)30368-0.
Article
Google Scholar
Jessen F, Amariglio RE, Van Boxtel M, Breteler M, Ceccaldi M, Chételat G, Initiative SCD, Subjective Cognitive Decline Initiative. A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer’s disease. Alzheimer’s & dementia. 2014;10(6):844–52. https://doi.org/10.1016/j.jalz.2014.01.001.
Article
Google Scholar
Ji H, Kim A, Ebinger JE, Niiranen TJ, Claggett BL, Merz CNB, Cheng S. Sex differences in blood pressure trajectories over the life course. JAMA cardiology. 2020;5(3):255–62. https://doi.org/10.1001/jamacardio.2019.5306.
Article
Google Scholar
Knopman DS, Jones DT, Greicius MD. Failure to demonstrate efficacy of aducanumab: an analysis of the EMERGE and ENGAGE trials as reported by Biogen, December 2019. Alzheimer’s & Dementia. 2021;17(4):696–701. https://doi.org/10.1002/alz.12213.
Article
Google Scholar
Koppara A, Wagner M, Lange C, Ernst A, Wiese B, König HH, Jessen F. Cognitive performance before and after the onset of subjective cognitive decline in old age. Alzheimer’s Dementia: Diagnosis, Assessment Disease Monitoring. 2015;1(2):194–205. https://doi.org/10.1016/j.dadm.2015.02.005.
Article
Google Scholar
Koran MEI, Wagener M, Hohman TJ. Sex differences in the association between AD biomarkers and cognitive decline. Brain Imaging Behavior. 2017;11(1):205–13. https://doi.org/10.1007/s11682-016-9523-8.
Article
Google Scholar
Lamar M, Wilson RS, Yu L, Stewart CC, Bennett DA, Boyle PA. Associations of decision making abilities with blood pressure values in older adults. J Hypertens. 2020;38(1):59–64. https://doi.org/10.1097/HJH.0000000000002220.
Article
CAS
Google Scholar
Laws KR, Irvine K, Gale TM. Sex differences in Alzheimer’s disease. Curr Opin Psychiatry. 2018;31(2):133–9. https://doi.org/10.1097/YCO.0000000000000401.
Article
Google Scholar
Levine DA, Gross AL, Briceño EM, Tilton N, Giordani BJ, Sussman JB, Galecki AT. Sex differences in cognitive decline among US adults. JAMA Netw Open. 2021;4(2):e210169–e210169. https://doi.org/10.1001/jamanetworkopen.2021.0169.
Article
Google Scholar
Liew TM. Depression, subjective cognitive decline, and the risk of neurocognitive disorders. Alzheimer’s Rese Ther. 2019;11(1):1–8. https://doi.org/10.1186/s13195-019-0527-7.
Article
Google Scholar
Lin KA, Choudhury KR, Rathakrishnan BG, Marks DM, Petrella JR, Doraiswamy PM, Alzheimer’s Disease Neuroimaging Initiative. Marked gender differences in progression of mild cognitive impairment over 8 years. Alzheimer’s Dementia. 2015;1(2):103–10. https://doi.org/10.1016/j.trci.2015.07.001.
Article
Google Scholar
Liu CC, Li CY, Sun Y, Hu SC. Gender and age differences and the trend in the incidence and prevalence of dementia and Alzheimer’s disease in Taiwan: a 7-year national population-based study. BioMed Res Int. 2019;2019. https://doi.org/10.1155/2019/5378540.
McLean CP, Asnaani A, Litz BT, Hofmann SG. Gender differences in anxiety disorders: prevalence, course of illness, comorbidity and burden of illness. J Psychiatr Res. 2011;45(8):1027–35. https://doi.org/10.1016/j.jpsychires.2011.03.006.
Article
Google Scholar
Mahase E. Aducanumab: European agency rejects Alzheimer’s drug over efficacy and safety concerns. BMJ. 2021;375:n3127. https://doi.org/10.1136/bmj.n3127.
Article
Google Scholar
Martinez JE, Pardilla-Delgado E, Guzmán-Vélez E, Vila-Castelar C, Amariglio R, Gatchel,J, Quiroz YT. Subjective cognitive decline and its relation to verbal memory and sex in cognitively unimpaired individuals from a Colombian cohort with autosomal-dominant Alzheimer’s disease. J Int Neuropsychological Soc. 2021:1-9. https://doi.org/10.1017/S1355617721000801.
McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH, Phelps CH. The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s dementia. 2011;7(3):263–9. https://doi.org/10.1016/j.jalz.2011.03.005.
Article
Google Scholar
Miller VM, Garovic VD, Kantarci K, Barnes JN, Jayachandran M, Mielke MM, Rocca WA. Sex-specific risk of cardiovascular disease and cognitive decline: pregnancy and menopause. Biol Sex Differ. 2013;4(1):1–15. https://doi.org/10.1186/2042-6410-4-6.
Article
CAS
Google Scholar
Montero-Odasso M, Zou GY, Kamkar N, Feldman HH, Belleville S, Chertkow H, Speechley M. Multidomain trials to prevent dementia: addressing methodological challenges. Alzheimer’s Res Ther. 2022;14(1):1–5. https://doi.org/10.1186/s13195-022-01036-1.
Article
Google Scholar
Morrison C, Dadar M, Shafiee N, Villeneuve S, Collins DL, Alzheimer’s Disease Neuroimaging Initiative. Regional brain atrophy and cognitive decline depend on definition of subjective cognitive decline. NeuroImage Clin. 2022;33:102923. https://doi.org/10.1016/j.nicl.2021.102923.
Article
Google Scholar
Morrison C, Dadar M, Villeneuve S, Ducharme S, Collins DL. White matter hyperintensity load varies depending on subjective cognitive decline criteria. GeroScience. 2022;1–12. https://doi.org/10.1007/s11357-022-00684-3.
Morrison C, Oliver MD. Subjective cognitive decline is associated with lower baseline cognition and increased rate of cognitive decline. J Gerontol: Series B. 2022. https://doi.org/10.1093/geronb/gbac178.
Niu H, Álvarez-Álvarez I, Guillén-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer’s disease in Europe: a meta-analysis. Neurología (English Edition). 2017;32(8):523–32. https://doi.org/10.1016/j.nrleng.2016.02.009.
Article
CAS
Google Scholar
Norton S, Matthews FE, Barnes DE, Yaffe K, Brayne C. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol. 2014;13(8):788–94. https://doi.org/10.1016/S1474-4422(14)70136-X.
Article
Google Scholar
Pérès K, Helmer C, Amieva H, Matharan F, Carcaillon L, Jacqmin-Gadda H, Dartigues JF. Gender differences in the prodromal signs of dementia: memory complaint and IADL-restriction. A prospective population-based cohort. J Alzheimer’s Dis. 2011;27(1):39–47. https://doi.org/10.3233/JAD-2011-110428.
Article
Google Scholar
Piccinelli M, Wilkinson G. Gender differences in depression: critical review. Br J Psychiatry. 2000;177(6):486–92. https://doi.org/10.1192/bjp.177.6.486.
Article
CAS
Google Scholar
Rabin LA, Smart CM, Amariglio RE. Subjective cognitive decline in preclinical Alzheimer’s disease. Annu Rev Clin Psychol. 2017;13:369–96. https://doi.org/10.1146/annurev-clinpsy-032816-045136.
Article
Google Scholar
Röhr S, Pabst A, Riedel-Heller SG, Jessen F, Turana Y, Handajani YS, Sachdev PS. Estimating prevalence of subjective cognitive decline in and across international cohort studies of aging: a COSMIC study. Alzheimer’s Res Ther. 2020;12(1):1–14. https://doi.org/10.1186/s13195-020-00734-y.
Article
Google Scholar
Schneider JA, Aggarwal NT, Barnes LL, Boyle P, Bennett DA. The neuropathology of older persons with and without dementia from community versus clinic cohorts. J Alzheimer’s Dis. 2009;18(3):691–701. https://doi.org/10.3233/JAD-2009-1227.
Article
Google Scholar
Selkoe DJ. The molecular pathology of Alzheimer’s disease. Neuron. 1991;6(4):487–98. https://doi.org/10.1016/0896-6273(91)90052-2.
Article
CAS
Google Scholar
Slot RE, Sikkes SA, Berkhof J, Brodaty H, Buckley R, Cavedo E, van der Flier WM. Subjective cognitive decline and rates of incident Alzheimer’s disease and non–Alzheimer’s disease dementia. Alzheimer’s Dementia. 2019;15(3):465–76. https://doi.org/10.1016/j.jalz.2018.10.003.
Article
Google Scholar
Sperling RA, Aisen PS, Beckett LA, Bennett DA, Craft S, Fagan AM, Phelps CH. Toward defining the preclinical stages of Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & dementia. 2011;7(3):280–92. https://doi.org/10.1016/j.jalz.2011.03.003.
Article
Google Scholar
Tampi RR, Forester BP, Agronin M. Aducanumab: evidence from clinical trial data and controversies. Drugs Context. 2021;10. https://doi.org/10.7573/dic.2021-7-3
Wang L, Tian T, Alzheimer’s Disease Neuroimaging Initiative. Gender differences in elderly with subjective cognitive decline. Front Aging Neurosci. 2018;10:166. https://doi.org/10.3389/fnagi.2018.00166.
Article
CAS
Google Scholar
Weisberg YJ, DeYoung CG, Hirsh JB. Gender differences in personality across the ten aspects of the Big Five. Front Psychol. 2011;2:178. https://doi.org/10.3389/fpsyg.2011.00178.
Article
Google Scholar
Wilson RS, De Leon CF, Barnes LL, Schneider JA, Bienias JL, Evans DA, Bennett DA. Participation in cognitively stimulating activities and risk of incident Alzheimer disease. Jama. 2002;287(6):742–8. https://doi.org/10.1001/jama.287.6.742.
Wright DB. (2017). Some limits using random slope models to measure academic growth. In Frontiers in Education (Vol. 2, p. 58). Frontiers Media SA. https://doi.org/10.3389/feduc.2017.00058.
Yiannopoulou KG, Anastasiou AI, Zachariou V, Pelidou SH. Reasons for failed trials of disease-modifying treatments for Alzheimer disease and their contribution in recent research. Biomedicines. 2019;7(4):97. https://doi.org/10.3390/biomedicines7040097.
Article
CAS
Google Scholar
Younes L, Albert M, Moghekar A, Soldan A, Pettigrew C, Miller MI. Identifying changepoints in biomarkers during the preclinical phase of Alzheimer’s disease. Front Aging Neurosci. 2019;11:74. https://doi.org/10.3389/fnagi.2019.00074.
Article
CAS
Google Scholar
Zhu D, Montagne A, Zhao Z. Alzheimer’s pathogenic mechanisms and underlying sex difference. Cell Mol Life Sci. 2021;78(11):4907–20. https://doi.org/10.1007/s00018-021-03830-w.
Article
CAS
Google Scholar